Hpse Antibody

What is HPSE and why is it significant in research applications?

HPSE (Heparanase) is an endoglycosidase that specifically cleaves heparan sulfate proteoglycans (HSPGs) into heparan sulfate side chains and core proteoglycans. It belongs to the glycosyl hydrolase 79 family and is also known by alternative names including HEP, HPA, HPA1, HPR1, HPSE1, and HSE1 . The significance of HPSE in research stems from its critical role in multiple biological processes, particularly in extracellular matrix remodeling and cellular migration.

The protein has a calculated molecular weight of approximately 61 kDa (543 amino acids) while the observed molecular weight in experimental conditions is approximately 60 kDa . This slight discrepancy between calculated and observed weights is common for glycoproteins and can provide valuable information about post-translational modifications when properly analyzed. Research applications focusing on HPSE are particularly important in cancer research, inflammation studies, and angiogenesis investigations due to its role in tissue remodeling.

What are the fundamental applications for HPSE antibodies in laboratory research?

HPSE antibodies demonstrate versatility across multiple experimental applications, making them valuable tools in research settings. Based on validated application data, the primary applications include:

What cell lines and tissues show positive reactivity with HPSE antibodies?

HPSE antibodies demonstrate reliable detection across multiple cell lines and tissue types. Based on extensive validation studies, positive Western blot detection has been confirmed in:

• HeLa cells

• HepG2 cells

• Jurkat cells

• Mouse liver tissue

For immunohistochemistry applications, positive detection has been achieved in:

• Human liver cancer tissue

• Human placenta tissue

Immunofluorescence applications have shown clear reactivity in:

• HeLa cells

• HepG2 cells

• NIH/3T3 cells

The reactivity profile shows that HPSE antibodies are particularly valuable for both human and mouse experimental systems, with evidence suggesting potential reactivity in rat models as well . When planning experiments with new cell lines or tissues not listed, preliminary validation is strongly recommended to establish optimal conditions.

What antigen retrieval methods are optimal for HPSE detection in fixed tissues?

Antigen retrieval is critical for successful HPSE detection in fixed tissue samples due to the masking of epitopes during fixation processes. Two principal methods are recommended for HPSE antibodies:

• Heat-Induced Epitope Retrieval (HIER):

  • Recommended buffer: TE buffer at pH 9.0 (primary recommendation)

  • Alternative buffer: Sodium citrate buffer at pH 6.0

  • Temperature parameters: >90°C for up to 30 minutes (optimal balance of epitope retrieval and tissue preservation)

  • Equipment options: Automated pressure cooker (preferred for consistency), steamer, microwave, or autoclave

• Microwave Heating Protocol:

  • Conduct two 5-minute heating cycles with a 1-minute rest interval between cycles

  • Maintain buffer levels to prevent tissue drying

The selection between HIER methods depends on laboratory equipment availability and tissue type. The inverse correlation between heating temperature and time should be considered when optimizing protocols (higher temperatures require shorter heating times) . For particularly challenging samples, enzymatic methods may be considered as alternatives.

How should researchers troubleshoot weak or non-specific signals in HPSE antibody applications?

When encountering weak or non-specific signals in HPSE antibody applications, a systematic troubleshooting approach is recommended:

For immunofluorescence applications specifically, nuclear counterstaining with DAPI improves localization accuracy, and dilution optimization between 1:100-1:500 for secondary antibodies is recommended based on demonstrated protocols . Additionally, for samples with longer fixation times, extending proteolytic digestion in PIER methods may improve epitope accessibility .

What controls should be incorporated when validating HPSE antibody specificity?

Rigorous validation of HPSE antibody specificity requires the incorporation of multiple controls:

• Positive Controls:

  • Use known HPSE-expressing cell lines (HeLa, HepG2, Jurkat)

  • Include positive tissue samples (human liver cancer, placenta)

• Negative Controls:

  • Primary antibody omission (to assess secondary antibody specificity)

  • Isotype controls (rabbit IgG at equivalent concentration)

  • Pre-absorption with immunizing peptide (when available)

• Expression Modulation Controls:

  • HPSE knockdown/knockout samples

  • HPSE overexpression systems

• Specificity Verification:

  • Molecular weight confirmation (observed at approximately 60 kDa)

  • Detection of expected expression patterns in tissues/cells

• Technical Validation:

  • Multiple antibody lots testing

  • Multiple detection methods (WB, IHC, IF) for concordance

Implementing this comprehensive validation strategy provides confidence in experimental results and reduces the risk of artifacts or misinterpretation. Documentation of these validation steps is increasingly required for publication in high-impact journals.

How can HPSE antibodies be optimized for multiplexed immunofluorescence applications?

Multiplexed immunofluorescence with HPSE antibodies requires careful optimization to prevent cross-reactivity and signal interference while maximizing detection sensitivity:

• Antibody Selection Strategy:

  • Choose primary antibodies from different host species when possible

  • If using multiple rabbit antibodies (like HPSE rabbit pAb), sequential staining with complete stripping between rounds is recommended

  • Validate spectral separation of selected fluorophores to prevent bleed-through

• Optimized Protocol:

  • Primary antibody dilution: 1:100 for HPSE antibody

  • Secondary antibody: Cy3-conjugated anti-rabbit IgG at 1:500

  • Counterstain: DAPI for nuclear visualization

  • Sequential imaging to minimize photobleaching

• Technical Considerations:

  • Implement proper controls for each antibody in the panel

  • Perform single-stain controls to establish baseline signals

  • Consider tyramide signal amplification for low-abundance targets

  • Use spectral unmixing for closely overlapping fluorophores

The integration of these approaches has been successfully demonstrated in NIH/3T3 and HeLa cells, providing clear subcellular localization data . For tissue sections, additional optimization may be required due to increased autofluorescence and reduced antibody penetration.

What quantitative approaches can accurately measure HPSE levels using antibody-based methods?

Accurate quantification of HPSE requires calibrated approaches tailored to specific experimental questions:

• Western Blot Quantification:

  • Load protein standards alongside samples (25μg per lane recommended)

  • Use internal loading controls (GAPDH, β-actin)

  • Employ digital image analysis with dynamic range validation

  • Apply four-parameter nonlinear regression for standard curves

• ELISA-Based Quantification:

  • Develop sandwich ELISA with anti-HPSE capture and detection antibodies

  • Generate standard curves using purified HPSE or validated cell lysates

  • Calculate concentrations by interpolation from standard curves

  • Validate with spike-recovery experiments (80-120% recovery indicates reliability)

• Immunofluorescence Quantification:

  • Standardize image acquisition parameters (exposure, gain)

  • Perform z-stack imaging for total protein assessment

  • Use automated image analysis platforms with validated algorithms

  • Include reference standards in each experimental batch

• Tissue Microarray Analysis:

  • Apply digital pathology scoring systems

  • Use machine learning algorithms for unbiased quantification

  • Incorporate multi-parameter analysis for contextual assessment

How can researchers effectively transition between different detection methods when using HPSE antibodies?

Transitioning between detection methods requires methodological adjustments to maintain consistent and comparable HPSE detection:

• From Western Blot to Immunohistochemistry:

  • Adjust antibody concentration (WB 1:1000-1:8000 → IHC 1:20-1:200)

  • Implement appropriate antigen retrieval (not required for WB)

  • Optimize incubation conditions (temperature, time)

  • Validate with known positive controls in both systems

• From Immunohistochemistry to Immunofluorescence:

  • Adjust antibody dilution (IHC 1:20-1:200 → IF 1:10-1:100)

  • Select compatible fluorophore-conjugated secondary antibodies

  • Implement measures to reduce autofluorescence

  • Assess signal-to-noise ratio in parallel with chromogenic detection

• From Cell Lines to Tissue Samples:

  • Adjust fixation protocols to tissue-specific requirements

  • Extend antigen retrieval time for densely fixed tissues

  • Consider tissue-specific blocking reagents to reduce background

  • Validate with known expression patterns in target tissues

• Cross-Platform Validation:

  • Confirm concordance between methods for the same sample

  • Document method-specific limitations

  • Standardize quantification approaches across platforms

  • Interpret differences in context of methodological constraints